M&A Deal Summary |
|
|---|---|
| Date | 2023-10-19 |
| Target | Instat Clinical Research |
| Sector | Business Services |
| Buyer(s) | Veristat |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1994 |
| Sector | Life Science |
Veristat is a scientifically minded global clinical research organization (CRO), enables biotech and pharmaceutical sponsors to solve unique and complex challenges associated with accelerating innovative therapies through clinical development to regulatory approval and post-approval. Veristat was founded in 1994 and is based in Southborough, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 8 of 8 |
| Sector: Business Services M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 8 of 8 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-11-11 |
DDR
Barcelona, Spain Drug Development and Regulation is an independent European consultancy with offices in Barcelona and Amsterdam, focused on providing appropriate scientific and regulatory expertise for the global development and registration of drugs and medical devices. The Company’s tailor-made solutions contribute to the success of clients’ development programs across quality, nonclinical, clinical, and regulatory functions. Drug Development and Regulation is based in Barcelona, Spain. |
Buy | - |
